HIV treatment and prevention on every 2026 Louisiana Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Louisiana cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | Humana Basic Rx Plan$0.00/moS5884-108 | Wellcare Value Script$5.70/moS4802-133 | Wellcare Classic$6.70/moS4802-012 | Humana Value Rx Plan$19.30/moS5884-200 | AARP Medicare Rx Saver from UHC$37.00/moS5921-366 | SilverScript Choice$44.70/moS5601-042 | HealthSpring Assurance Rx$48.40/moS5617-103 | HealthSpring Extra Rx$60.60/moS5617-371 | Humana Premier Rx Plan$113.70/moS5884-167 | AARP Medicare Rx Preferred from UHC$139.50/moS5921-402 |
|---|---|---|---|---|---|---|---|---|---|---|
| Biktarvybictegravir/emtricitabine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 533%QL 30/30d | Tier 531%QL 30/30d |
| Dovatodolutegravir and lamivudine | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 533%QL 30/30d | Tier 531%QL 30/30d |
| Triumeqabacavir/dolutegravir/lamivudine | Tier 432%QL 180/30d | Tier 440% | Tier 428% | Tier 435%QL 180/30d | Tier 440%QL 180/30d | Tier 435% | Tier 430%QL 300/30d | Tier 430%QL 300/30d | Tier 450%QL 180/30d | Tier 436%QL 180/30d |
| Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 531%QL 30/30d |
| Odefseyemtricitabine/rilpivirine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 531%QL 30/30d |
| Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 533%QL 30/30d | Tier 531%QL 30/30d |
| Julucadolutegravir and rilpivirine | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 525% | Tier 533%QL 30/30d | Tier 531%QL 30/30d |
| Descovyemtricitabine and tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 533%QL 30/30d | Tier 531%QL 30/30d |
| Truvadaemtricitabine and tenofovir disoproxil | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| emtricitabine-tenofovirgeneric Truvada | Tier 432%QL 30/30d | Tier 440%QL 30/30d | Tier 428%QL 30/30d | Tier 435%QL 30/30d | Tier 440%QL 30/30d | Tier 435%QL 30/30d | Tier 430%QL 30/30d | Tier 430%QL 30/30d | Tier 450%QL 30/30d | Tier 436%QL 30/30d |
| Tivicaydolutegravir | Tier 525%QL 60/30d | Tier 525% | Tier 525% | Tier 526%QL 60/30d | Tier 525%QL 60/30d | Tier 525% | Tier 430%QL 180/30d | Tier 430%QL 180/30d | Tier 533%QL 60/30d | Tier 531%QL 60/30d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.